Anavex Life Sciences (AVXL)
(Delayed Data from NSDQ)
$5.15 USD
-0.41 (-7.37%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $5.14 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/25/2024
Time: -- |
9/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, Anavex Life Sciences (AVXL) reported earnings of -$0.14 per share, beating the Zacks Consensus Estimate of $-0.15 per share. This reflects a positive earnings surprise of 6.67%. Look out for AVXL's next earnings release expected on November 25, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year decrease of 41.67%.
Earnings History
Price & Consensus
Zacks News for AVXL
HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails
AVXL: What are Zacks experts saying now?
Zacks Private Portfolio Services